6-Bromo-1-methyl-1,3-dihydrobenzo[c][1,2,5]thiadiazole 2,2-dioxide, 97%, 1g

n,n-Dimethyl-2-(2-methylphenoxy)acetamide, 97%, 500mg

Trial kit Spectra/Por® 1-3 Spectra/Por® 1 – MWCO 6000–8000, 50 mm, 1 Piece(s)

6-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine, 95.0%, 250mg

Methylaminoacetaldehyde Dimethyl Acetal>98.0%(GC)(T)500mL

Sodium prop-2-ene-1-sulfonate, 95.0%, 25g

1-Phenoxypropan-2-one, 95.0%, 5g

2-Methylpyrrolidine hydrochloride, 97.0%, 5g

3-Allyl-1,5-naphthyridine, 95+%, 250mg

6-methoxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carbaldehyde, 95.0%, 1g

4-Amino-2-chloro-5-fluorobenzonitrile, 95.0%, 250mg

(2-Cyanopyrimidin-5-yl)boronic acid, 98%, 5g

Malonic acid, min. 99%, for synthesis, 1 kg, glass packaging